Диссертация (1139542), страница 58
Текст из файла (страница 58)
44. ‒ P.579-581.Williams C. А., Lopes P. The influence of ventilatory control on heart rate variability inchildren. // J. Sport Sciences ‒2002. ‒ V. 20, № 5. ‒ P. 407-415.Wilson A. M. The role of antihistamines in asthma management. // Treat Respir Med. ‒2006. ‒ V. 5, № 3. ‒ P.
149-58.Wine J. J. Parasympathetic control of airway submucosal glands: Central reflexes and theairway intrinsic nervous system. // Autonomic Neuroscience. ‒ 2007. ‒ V. 133, № 1. ‒ P.35-54.Winsley R. J., Armstrong N., al. e. Reliability of heart rate variability measures at rest andduring light exercise in children. // Br.
J. Sports Med. ‒ 2003. ‒ V. 37. ‒ P. 550-552.312498499500501502503504505506507508509510Wöhrl S., Gamper S., Hemmer W., Heinze G., Stingl G., Kinaciyan T. Premedication withmontelukast reduces local reactions of allergen immunotherapy. // Int Arch AllergyImmunol. . ‒ 2007. ‒ V. 144, № 2. ‒ P. 137-142.Wood L. G., Baines K. J., Fu J.
J., Scott H. A., Gibson P. G. The neutrophilic inflammatoryphenotype is associated with systemic inflammation in asthma. // Chest. ‒ 2012 ‒V. 142, №1. ‒ P. 86-93.Wood L. G., Fitzgerald D. A., Gibson P. G., Cooper D. M., Garg M. L. Lipid peroxidationas determined by plasma isoprostanes is related to disease severity in mild asthma // Lipids.‒ 2000. ‒ V.
35, № 9. ‒ P. 967-974.Wood L. G., Gibson P. G., Garg M. L. Biomarkers of lipid peroxidation, airwayinflammation and asthma // Eur Respir J. ‒ 2003. ‒ V. 21, № 1. ‒ P. 177-186.Woodruff P. G., Khashayar R., Lazarus S. C., Janson S., Avila P. C., Boushey H. A., SegalM., J.V. F. Relationship between airway inflammation, hyperresponsiveness, andobstruction in asthma. // J Allergy Clin Immunol ‒2001. ‒ V. 108. ‒ P. 753-758.Wun Y. T., Chan M. S., Wong N. M., et al. A curvilinear nomogram of peak expiratoryflow rate for the young. // J Asthma. ‒ 2013.
‒ V. 50, № 1. ‒ P. 39-44.Yao D., Vlessidis A. G., Evmiridis N. P. Determination of Nitric Oxide in BiologicalSamples // Microchimica Acta. ‒ 2004. ‒ V. 147. ‒ P. 1-20.Yeatts K., Svendsen E., al. e. Coarse particulate Matter (PM2.5-10) affects heart ratevariability, blood lipids, and circulating eosiniphils in adults with asthma.
// EnviromentalHealth Perspectives. ‒ 2007. ‒ V. 115, № 5. ‒ P. 709-714.Zacharasiewicz A., Wilson N., Lex C., Erin E. M., Li A. M., Hansel T., Khan M., Bush A.Clinical use of noninvasive measurements of airway inflammation in steroid reduction inchildren // Am J Respir Crit Care Med. ‒ 2005.
‒ V. 171, № 10. ‒ P. 1077-1082.Zervas E., Oikonomiodou E., Kainis E., Kokkala M., Petroheilou K., Gaga M. Review:Control of asthma. // Ther Adv Respir Dis. ‒ 2008. ‒ V. 2. ‒ P. 141-148.Zhang T., Finn D. F., Barlow J. W., Walsh J. J. Mast cell stabilisers. // Eur J Pharmacol. 2015.
‒ C. S0014-2999(15)30097-2.Zinellu A., Fois A. G., Sotgia S., Zinellu E., Bifulco F., et al. Plasma protein thiols: an earlymarker of oxidative stress in asthma and chronic obstructive pulmonary disease. // Eur JClin Invest.- 2016. ‒ C. 181-188.Zissler U. M., Esser-von Bieren J., Jakwerth C. A., Chaker A. M., Schmidt-Weber C. B.Current and future biomarkers in allergic asthma. // Allergy. - 2016. ‒ C. 475-494.313.